Brief: Prostatype Genomics Submits Medicare Reimbursement Application In U.S. Market For Gene Test Prostatype
Sept 30 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* SUBMITS MEDICARE REIMBURSEMENT APPLICATION IN THE US
MARKET FOR
ITS GENE TEST PROSTATYPE
Source text for Eikon: ID:nMFNgMbYl
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Cannot Specify Timing For Final Medicare Decision
Brief: Prostatype Genomics Enters SEK 6.0 Mln Agreement With Vator Securities For To6
Brief: Prostatype Genomics AB H1 2026 Net Sales SEK 457,000
Brief: Prostatype Genomics Resolves On Directed Issue
Brief: Prostatype Genomics To Receive About SEK 47.4 Mln From Rights Issue